Our results showed that DNA damage was ameliorated in NRIP3-overexpressing cells when cells were treated with aphidicolin (an inhibitor of replicative polymerase), cisplatin and IR, suggesting that NRIP3 confers upon ESCC cell resistance to replicative stress and CRT. The gene discussed is NRIP3; the disease is esophageal squamous cell carcinoma.